276 related articles for article (PubMed ID: 29434067)
1. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
[TBL] [Abstract][Full Text] [Related]
2. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor.
Fechner H; Pinkert S; Wang X; Sipo I; Suckau L; Kurreck J; Dörner A; Sollerbrant K; Zeichhardt H; Grunert HP; Vetter R; Schultheiss HP; Poller W
Gene Ther; 2007 Jun; 14(12):960-71. PubMed ID: 17377597
[TBL] [Abstract][Full Text] [Related]
4. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
5. CVB infection and mechanisms of viral cardiomyopathy.
Knowlton KU
Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
[TBL] [Abstract][Full Text] [Related]
6. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
7. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
[TBL] [Abstract][Full Text] [Related]
8. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
9. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
[TBL] [Abstract][Full Text] [Related]
10. Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.
Callon D; Glenet M; Lebreil AL; Heng L; Bouland N; Fichel C; Fornes P; Andreoletti L; Berri F
PLoS Pathog; 2024 May; 20(5):e1012125. PubMed ID: 38696536
[TBL] [Abstract][Full Text] [Related]
11. Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.
Werner B; Dittmann S; Funke C; Überla K; Piper C; Niehaus K; Horstkotte D; Farr M
Inflamm Res; 2014 Apr; 63(4):267-76. PubMed ID: 24316867
[TBL] [Abstract][Full Text] [Related]
12. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
[TBL] [Abstract][Full Text] [Related]
13. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
[TBL] [Abstract][Full Text] [Related]
14. The role of B lymphocytes in coxsackievirus B3 infection.
Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
[TBL] [Abstract][Full Text] [Related]
15. Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.
Werk D; Pinkert S; Heim A; Zeichhardt H; Grunert HP; Poller W; Erdmann VA; Fechner H; Kurreck J
Antiviral Res; 2009 Sep; 83(3):298-306. PubMed ID: 19591879
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection.
Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S
Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of virus infection in coxsackievirus-induced myocarditis model by RNA interference].
Yao HL; He F; Xiao ZH; Liu ZW
Bing Du Xue Bao; 2012 Sep; 28(5):527-30. PubMed ID: 23233928
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
